JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 34 No. 6 927-931
© 1993 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dahlberg, S. T.
Right arrow Articles by Leppo, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dahlberg, S. T.
Right arrow Articles by Leppo, J. A.

Myocardial Extraction of Technetium-99m-[2-(1-Methoxybutyl) Isonitrile] in the Isolated Rabbit Heart: A Myocardial Perfusion Agent with High Extraction and Stable Retention

Seth T. Dahlberg, Denis J. Meerdink, Madeleine P. Gilmore and Jeffrey A. Leppo

Departments of Nuclear Medicine and Medicine (Division of Cardiology), University of Massachusetts Medical Center, Worcester, Massachusetts
Department of Physiology, University of the Pacific, Stockton, California

Correspondence: For correspondence or reprints contact: Seth T. Dahlberg, MD, Department of Nuclear Medicine, University of Massachusetts Medical Center, 55 Lake Avenue North, Worcester, MA 01655.

ABSTRACT

Technetium-99m-[2-(1-methoxybutyl) isonitrile] (MBI) is a potential new compound for the scintigraphic imaging of coronary flow. Evaluation in the blood-perfused isolated rabbit heart model showed this compound to have a myocardial uptake comparable to 201Tl and higher than sestamibi. Although the mean ± s.d. maximum extraction (Emax and capillary permeability-surface area product (PScap) of 99mTc-MBI (Emax = 0.45 ± 0.10, PScap = 1.07 ± 0.47 ml/min · g) were much less than 201 (Emax = 0.71 ± 0.07, PScap = 2.21 ± 0.76 ml/min · g, p < 0.0001), the net extraction of 99mTc-MBI (Enet = 0.52 ± 0.10) was only slightly less than the value for 201Tl (Enet = 0.56 ± 0.10, p < 0.05). There was no significant difference in the myocardial uptake versus flow between 99mTc-MBI and 201Tl. These data indicate that assessment of relative coronary flow based on the myocardial uptake of 99mTc-MBI should give results comparable to 201Tl. Therefore, 99mTc-MBI may have clinical potential as a radiolabeled myocardial perfusion agent.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1993 by the Society of Nuclear Medicine.